Aktan Alpsoy
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
104
Citations
1,036
Est. group size
~7
Recurring co-author estimate
Active years
13
Publishing since 2014
Aktan Alpsoy's research focuses on cancer molecular biology, particularly how the YAP/TAZ signaling pathway (a set of proteins that control cell growth and are often abnormally active in cancer) is regulated, including by kinases called MARK2 and MARK3. Recent work also involves developing gene-editing tools, such as inducible base editors, to study cancer genes directly in living organisms. This research combines cell biology, cancer genetics, and molecular tool development.
Publication output was low and sporadic from 2017–2022 but increased sharply from 2023 onward, suggesting a recent period of growing research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Inducible, split base editors for in vivo cancer functional genomics
Nature Biotechnology · 2026
- Supplementary Table S1 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S9 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S6 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S3 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S5 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S10 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S11 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S2 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S6 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S3 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S1 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Figure S5 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S4 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- Supplementary Table S9 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Cell Reports×2
- ChemRxiv×2
- Journal of Biological Chemistry×1
- Nature Chemical Biology×1
- Juan Peng
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Clark D. Wells
Biochemistry, Genetics and Molecular Biology · Indiana University
- Emily M. King
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jacob J. Adler
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Jennifer A. Perry
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile